Heart inflammation emerges in a Sarepta Duchenne patient, clouding an otherwise positive readout - Endpoints News

Having already secured several approvals for Duchenne muscular dystrophy drugs, Sarepta aimed to capitalize on its lead in the field with a new data readout Wednesday. And while many of the hard numbers are positive, a new side effect is putting a damper on t…

Having already secured several approvals for Duchenne muscular dystrophy drugs, Sarepta aimed to capitalize on its lead in the field with a new data readout Wednesday. And while many of the hard numb… [+672 chars]

full article...